FDA
-
-
-
-
-
-
-
Galera Adopts Limited Duration Stockholder Rights Agreement
-
-
-
-
-
-
-
Galera to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
-
-
-
-
-
-
-
Galera Reports First Quarter 2023 Financial Results and Recent Corporate Updates
-
-
-
-
-
-
-
Galera Therapeutics (GRTX) Presentation of Supplemental Analysis of Phase 3 ROMAN Trial at European Congress on Head and Neck Oncology
-
-
-
-
-
-
-
Galera Therapeutics (GRTX) Prices 14.32M Share Offering at $2.10/sh
-
-
-
-
-
-
-
Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis
-
-
-
-
-
-
-
Galera to Present at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

